Daniel J. Carlat, MD: Commentary on the Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials

Name: Daniel J. Carlat, MD: Commentary on the Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials
SKU: 4537
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 40 No. 3 Articles Tags: daniel-j-carlat, md, medworks-media, psychopharmacology, psychopharmacology-bulletin

Description

Description

Daniel J. Carlat, MD Link

COMMENTARY

Commentary on the Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials

Daniel J. Carlat, MD: Commentary on the Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials

Description

Daniel J. Carlat, MD Link

COMMENTARY

Commentary on the Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials

Daniel J. Carlat,MD

Trazodone for Depressed Mood, Anxiety, Insomnia, and Suicidality

Schizophrenia Rating Scales Critical Review by Takefumi Suzuki

Test of Treatment in Psychiatric Practice by Feras Ali Mustafa

Paroxysmal Perceptual Alteration Case Study by Samir Kumar Praharaj

Daniel J. Carlat, MD: Commentary on the Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials

Description

Daniel J. Carlat, MD Link

COMMENTARY

Commentary on the Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials

Daniel J. Carlat,MD

Related products

Trazodone for Depressed Mood, Anxiety, Insomnia, and Suicidality

Schizophrenia Rating Scales Critical Review by Takefumi Suzuki

Test of Treatment in Psychiatric Practice by Feras Ali Mustafa

Paroxysmal Perceptual Alteration Case Study by Samir Kumar Praharaj